A controlled trial of the effect of the 5-lipoxygenase inhibitor, zileuton, on lung inflammation produced by segmental antigen challenge in human beings
- 29 February 1996
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 97 (2) , 646-654
- https://doi.org/10.1016/s0091-6749(96)70310-x